Safety and effectiveness of clazosentan in patients after aneurysmal subarachnoid haemorrhage: a second interim report of a post-marketing surveillance in Japan

Hiroyuki Sakata, Yuya Takayama, Yuna Iwasaki, Hiroyuki Uchida, Satoshi Nishimoto, Osamu Togo

Open source

DOI
10.1007/s10143-026-04240-x
Published
2026-03-31
Container
Neurosurgical Review
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10143-026-04240-x,
  title = {Safety and effectiveness of clazosentan in patients after aneurysmal subarachnoid haemorrhage: a second interim report of a post-marketing surveillance in Japan},
  author = {Hiroyuki Sakata and Yuya Takayama and Yuna Iwasaki and Hiroyuki Uchida and Satoshi Nishimoto and Osamu Togo},
  year = {2026},
  journal = {Neurosurgical Review},
  doi = {10.1007/s10143-026-04240-x},
  url = {https://doi.org/10.1007/s10143-026-04240-x}
}

RIS

TY  - JOUR
TI  - Safety and effectiveness of clazosentan in patients after aneurysmal subarachnoid haemorrhage: a second interim report of a post-marketing surveillance in Japan
AU  - Hiroyuki Sakata
AU  - Yuya Takayama
AU  - Yuna Iwasaki
AU  - Hiroyuki Uchida
AU  - Satoshi Nishimoto
AU  - Osamu Togo
PY  - 2026
JO  - Neurosurgical Review
DO  - 10.1007/s10143-026-04240-x
UR  - https://doi.org/10.1007/s10143-026-04240-x
ER  - 

APA

Sakata, H., Takayama, Y., Iwasaki, Y., Uchida, H., Nishimoto, S., & Togo, O. (2026). Safety and effectiveness of clazosentan in patients after aneurysmal subarachnoid haemorrhage: a second interim report of a post-marketing surveillance in Japan. Neurosurgical Review. https://doi.org/10.1007/s10143-026-04240-x

Source records